Scarica l'app Stockscreener
4.02
0.25%
-0.01
Precedente Chiudi:
$4.03
Aprire:
$4.04
Volume 24 ore:
1.66M
Relative Volume:
0.36
Capitalizzazione di mercato:
$490.45M
Reddito:
$43.40M
Utile/perdita netta:
$-68.98M
Rapporto P/E:
-7.7877
EPS:
-0.5162
Flusso di cassa netto:
$-50.94M
1 W Prestazione:
-4.74%
1M Prestazione:
+10.14%
6M Prestazione:
-20.40%
1 anno Prestazione:
+47.79%
Intervallo 1D:
$3.965
$4.11
Intervallo di 1 settimana:
$3.965
$4.41
Portata 52W:
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Nome
Aquestive Therapeutics Inc
Settore
Telefono
908-941-1900
Indirizzo
30 TECHNOLOGY DRIVE, WARREN, NJ
Compare AQST vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
4.02 | 490.45M | 43.40M | -68.98M | -50.94M | -0.5162 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.77 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.62 | 48.81B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.03 | 44.67B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.57 | 33.27B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
536.12 | 23.50B | 3.18B | 1.33B | 1.04B | 27.90 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2024-12-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-10 | Iniziato | Leerink Partners | Outperform |
| 2024-04-11 | Iniziato | Piper Sandler | Overweight |
| 2024-03-28 | Iniziato | Raymond James | Outperform |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-04-22 | Iniziato | H.C. Wainwright | Buy |
| 2019-01-03 | Iniziato | Lake Street | Buy |
| 2018-08-20 | Iniziato | JMP Securities | Mkt Outperform |
| 2018-08-20 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie
What’s the RSI of Aquestive Therapeutics Inc. stockJuly 2025 Gainers & Safe Entry Momentum Stock Tips - mfd.ru
FinancialContentAQST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - FinancialContent
ROSEN Law Firm Encourages Aquestive Therapeutics Investors to Secure Counsel Before Deadline - National Today
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ENPH - GlobeNewswire Inc.
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to ... - bdtonline.com
Aquestive Therapeutics SVP Cioffi sells $105k in shares - Investing.com Nigeria
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
2026-03-13 | AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST) - Seeking Alpha
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - Sahm
AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 - Sahm
Class Action Lawsuit Filed Against Aquestive Therapeutics - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesAQST - PR Newswire
Aquestive Therapeutics Investors Eligible for Securities Fraud Lawsuit - National Today
Bronstein, Gewirtz & Grossman LLC Urges Aquestive - GlobeNewswire
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive ... - bdtonline.com
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT - GlobeNewswire
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Aquestive therapeutics chief legal officer Braender sells $167k in stock - Investing.com Canada
Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors - Carroll County Mirror-Democrat
Aquestive Therapeutics SVP Cioffi sells $105k in shares By Investing.com - Investing.com Canada
Aquestive Therapeutics CEO Barber sells $753,965 in stock By Investing.com - Investing.com Canada
Aquestive Therapeutics CEO Barber sells $753,965 in stock - Investing.com
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) COO Sells 45,791 Shares of Stock - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Insider Peter Boyd Sells 29,814 Shares - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) SVP Melina Cioffi Sells 25,311 Shares - MarketBeat
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) CFO Sells 58,254 Shares of Stock - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Insider Lori Braender Sells 40,102 Shares - MarketBeat
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) CEO Sells 180,677 Shares of Stock - MarketBeat
Aquestive (AQST) CCO granted stock and options, sells shares to cover taxes - Stock Titan
Aquestive Therapeutics (AQST) COO reports equity grants and tax sale - Stock Titan
Aquestive (NASDAQ: AQST) CDO receives 50,000-share stock and option grants - Stock Titan
AQST Investors Encouraged to Seek Lead Plaintiff Role in Aquestive Therapeutics Securities Class Action Case with Johnson Fistel - lincolnjournal.com
Aquestive Therapeutics (AQST) CMO discloses 2,000 indirectly held shares on Form 3 - Stock Titan
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
HC Wainwright Issues Optimistic Forecast for AQST Earnings - MarketBeat
Aquestive Therapeutics: With Some Hiccups, Anaphylm Is Closer To FDA Approval - Seeking Alpha
Aquestive Therapeutics Targets Q3 Anaphylm Resubmission After FDA CRL Flags Human Factors, PK Data - MarketBeat
AQUESTIVE THERAPEUTICS, INC. (AQST) DEADLINE ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline - ACCESS Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive - GlobeNewswire
Rosen Law Firm Urges Aquestive Therapeutics, Inc. (NASDAQ: AQST) Stockholders to Contact the Firm for Information About Their Rights - The Joplin Globe
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Claims CEO Allegedly Misrepresented Company Prospects: Levi & Korsinsky - Business Wire
AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 - TMX Newsfile
Class Action Filed Against Aquestive Therapeutics, Inc. (AQST) S - GuruFocus
AQST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Class Action Filed Against Aquestive Therapeutics, Inc. (AQST) Seeking Recovery for InvestorsContact The Gross Law Firm - Barchart.com
Oppenheimer Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST) - The Globe and Mail
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
2026-03-10 | AQST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
Aquestive Therapeutics Inc Azioni (AQST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.15%
3.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):